Malarvx Inc.

Seattle, WA

UEI
CJW3FAAV9KA6
CAGE
6WZ79
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1551 Eastlake Ave E #100, Seattle, WA 98102, USA
Website
malarvx.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Biological equivalence of in vitro plasmodium falciparum culture for practical malaria vaccine development R43AI149889 National Institute of Allergy and Infectious Diseases (NIH) $881,774
Toward intradermal/subcutaneous delivery of whole sporozoites for plasmodium falciparum malaria vaccines W81XWH1920015 Medical Command (Army) $107,346

Quick answers

Is Malarvx Inc. registered in SAM.gov?

Yes. Malarvx Inc.'s SAM.gov registration is active through March 11, 2027.

What is Malarvx Inc.'s most recent federal award?

Malarvx Inc.'s most recent federal grant award is Biological equivalence of in vitro plasmodium falciparum culture for practical malaria vaccine development (R43AI149889), from National Institute of Allergy and Infectious Diseases (NIH), on September 21, 2020.

On GovTribe

See Malarvx Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login